Written and maintained by CASRAI Editorial Board
Last updated
Biomedical equipment inventory management is the discipline of maintaining an accurate, current record of every piece of durable biomedical equipment an institution owns — what it is, where it is, what condition it is in, and how long it is expected to remain in service — and using that record to drive three separate downstream decisions: preventive maintenance scheduling, capital budgeting, and replace-versus-repair calls. It sits underneath, and feeds, several more specific programs CASRAI covers elsewhere: the Joint Commission-mandated medical equipment management plan, the biomedical equipment maintenance program a Healthcare Technology Management (HTM) department runs day to day, and the finance office’s depreciation schedule. This guide covers the inventory record itself: what belongs in it, how equipment gets physically tagged and tracked, why “useful life” means two different things to two different departments, and a practical framework for deciding whether an aging unit gets repaired again or replaced.
Scope note: this guide is about durable, capital-tracked equipment — infusion pumps, patient monitors, imaging systems, sterilizers, analyzers, surgical equipment — not consumable lab samples or reagents. For barcode/RFID tracking of specimens, tubes, and consumable inventory, see barcode and RFID labeling for lab sample and inventory tracking, which covers a genuinely different tagging problem (single-use, freezer-stored, high-volume items) than the one this guide addresses.
What Belongs in an Equipment Inventory Record
A usable equipment inventory record is more than an asset tag number and a location. At minimum, each entry needs to carry:
- Identification — a unique internal asset ID (independent of manufacturer serial number, which can repeat across models or be reused by the manufacturer), plus manufacturer, model, and serial number as separate fields
- Acquisition data — purchase date, acquisition cost, funding source (institutional capital budget, departmental operating budget, or a specific federal award — see the federal-award note below), and PO or contract reference
- Location and custodianship — current department/room, and who is accountable for the device if it moves or is loaned between departments
- Risk classification — whether the device falls into a high-risk category (life support, anesthetizing-location use, or subject to an active hazard notice or recall) that determines inclusion criteria and maintenance rigor, per the risk-scoring approach covered in the medical equipment management plan guide
- Maintenance reference — the assigned preventive-maintenance interval and strategy (manufacturer schedule or an Alternative Equipment Maintenance designation), not the maintenance history itself, which typically lives in a separate work-order log
- Financial-life reference — a pointer to the asset’s depreciation schedule (see below) rather than duplicating the full schedule in the inventory system
- Disposition status — active, in repair, retired/surplus, or disposed, with the date and method of disposition recorded once a unit leaves service
Most institutions maintain this record in a Computerized Maintenance Management System (CMMS) or Enterprise Asset Management (EAM) platform rather than a spreadsheet once the fleet grows past a few dozen tracked devices — CASRAI’s laboratory asset management software guide covers how to evaluate that category of tool in depth; this guide focuses on what the record itself needs to contain and how it gets populated and kept current, regardless of which system holds it.
Asset-Tagging Methodology: Barcode and RFID for Durable Equipment
Tagging durable, multi-year equipment is a different physical problem than tagging a consumable or a sample. A tag on an infusion pump or a patient monitor has to survive years of handling, repeated disinfectant wipe-downs, and — for some equipment classes — a stint in a decontamination or sterile-processing workflow, rather than surviving a single freeze-thaw cycle or a single use. That durability requirement shapes which tagging technology fits which asset class.
Barcode asset tags
Most equipment inventory programs use a printed, laminated, or metal-foil barcode asset tag physically affixed to the unit, encoding the internal asset ID as either a 1D (linear) barcode or a 2D code (Data Matrix or QR). The tag is a pointer, not a data store: scanning it looks up the full record in the CMMS/EAM system rather than carrying the asset’s history on the label itself. Tag durability matters more here than for a consumable label — a tag that has to survive the working life of a ventilator or an ultrasound system (often a decade or more) needs adhesive and print media rated for repeated alcohol or quaternary-ammonium disinfectant exposure, not the standard paper label stock adequate for a one-time-use item.
RFID for equipment location and tracking
Radio-frequency identification adds a capability barcode tagging doesn’t have on its own: a scanner (or a fixed reader infrastructure) can detect a tagged asset’s presence or location without direct line-of-sight or a deliberate scan action. Passive RFID tags (no internal battery, powered by the reader’s signal) are cheap enough to apply broadly across a fleet and are read at close range — useful for confirming an asset’s presence during a physical inventory audit without unpacking or repositioning it. Active RFID tags carry their own battery and broadcast continuously, which is what underlies real-time location system (RTLS) deployments that let a hospital locate a specific infusion pump or wheelchair across an entire facility on a live map — a meaningfully bigger infrastructure investment (fixed readers throughout the building, not just handheld scanners) that institutions typically justify only for high-value, frequently-misplaced, or high-utilization equipment classes rather than the entire inventory.
Where the FDA’s Unique Device Identifier fits
Separately from an institution’s own internal asset tag, many biomedical devices already carry a manufacturer-applied Unique Device Identifier (UDI) on their label, required under the FDA’s UDI rule (21 CFR Part 801, Subpart B, and Part 830), phased in by device class over several years starting with Class III devices. A UDI consists of a Device Identifier (a fixed code identifying the specific model, tied to the manufacturer’s listing in FDA’s Global Unique Device Identification Database, GUDID) and a Production Identifier (lot number, serial number, and/or expiration/manufacture date, which varies unit-to-unit). The UDI is not a substitute for an institution’s internal asset tag — it identifies the device model and production batch, not which department owns this specific unit or when it’s next due for preventive maintenance — but capturing the UDI’s Device Identifier at receipt is a useful addition to the inventory record: it gives a clean, standardized cross-reference back to the manufacturer’s own device data if a recall or hazard notice is issued against that model.
Useful Life vs. Depreciation Schedule: Two Numbers, Tracked by Two Different Departments
An equipment inventory record almost always ends up carrying two distinct “how long does this last” numbers, and conflating them is a common source of confusion between finance and clinical/biomedical engineering staff:
- The depreciation life — a finance-office number, and in the US almost always two sub-numbers: the tax depreciation life under MACRS (a fixed period from IRS asset-class tables) and the book/GAAP useful life the institution’s own accounting policy assigns, commonly benchmarked against the American Hospital Association/ASHE published useful-life tables for hospital equipment categories. Neither number is a prediction of when the equipment will actually fail or become unsafe to operate — they’re accounting inputs for a capital budget, an indirect-cost proposal, or a financial statement. CASRAI’s medical equipment depreciation life guide covers this pairing in full depth, including where the reference tables come from; see capital equipment depreciation schedule for the calculation mechanics once a useful-life figure is set.
- The operational/clinical-engineering service-life estimate — a separate, condition-based judgment HTM or biomedical engineering staff form from the device’s actual failure history, cumulative cycle or usage count, parts-availability status with the manufacturer, and how the unit compares to typical service-life benchmarks for its equipment category. This number can diverge meaningfully from the accounting useful life in either direction: a well-maintained, low-utilization device can remain clinically serviceable well past the end of its book depreciation period, while a heavily cycled unit with a rising repair frequency can reach the end of its practical service life while it’s still carrying book value on the balance sheet.
Both numbers belong in the inventory record, as separate fields, because they answer different questions for different audiences: the depreciation life tells finance when the asset is fully written down and feeds capital-budget planning; the operational estimate tells clinical/biomedical engineering when the device is becoming a maintenance and safety liability regardless of its book status. A capital replacement plan that relies on the depreciation schedule alone routinely misses equipment that needs replacing early (heavy use, poor parts availability) and defers equipment that’s still functioning well simply because its book life expired.
The Replace-vs-Repair Decision Framework
When a piece of aging equipment fails or needs a costly repair, the decision to fix it again or replace it should draw on the inventory record rather than being made ad hoc by whoever happens to be evaluating the failure. Two inputs matter most, and neither is decisive alone:
Age relative to typical service life for the equipment category
Calendar age on its own is a weak signal — the same model can remain reliable at twelve years in a low-utilization setting or become a liability at five years under heavy cycling with deferred maintenance, the same variability CASRAI’s autoclave repair-vs-replace guide documents in detail for one equipment category. What matters is age relative to the typical service-life range for that equipment class, combined with condition signs: rising repair frequency (several service calls in a period that used to need one), physical wear that a parts swap doesn’t fully correct, cycle-time or throughput degradation, or the manufacturer discontinuing parts or firmware support for the model. Two or more of those signs occurring together, on a unit already inside or past its typical service-life range, is a stronger indicator than age alone.
Repair-cost ratio
Many equipment-management programs apply a simple repair-cost-ratio heuristic alongside the age/condition assessment: compare the cost of the repair at hand — or the cumulative repair spend on that specific unit over a recent period — against the cost of a new replacement. A single repair estimate that approaches half or more of replacement cost is a strong signal to replace rather than repair, since the institution is committing a large fraction of a new unit’s price to extend the life of a device that will likely need another significant repair before long. Cumulative repair spend matters as much as any single quote: a unit that’s had three “small” repairs in eighteen months can have consumed as much budget as a replacement would have cost, without anyone treating any single repair as the trigger point.
| Signal combination | Typical disposition |
|---|---|
| Within typical service-life range, isolated repair < ~20% of replacement cost | Repair — routine maintenance spend |
| Approaching end of typical service-life range, repair cost 20-50% of replacement, no other condition flags | Repair, but flag for near-term capital replacement planning |
| At or past typical service-life range, repair cost > 50% of replacement, and/or two or more condition flags present | Replace — route through capital procurement rather than an operating-expense repair |
| Any age, but subject to an active hazard notice/recall the repair won’t resolve, or parts/firmware no longer supported | Replace, regardless of where the repair-cost ratio otherwise lands |
This decision also needs to route through the right budget mechanism. A repair is typically an operating expense against a service contract or parts/labor purchase order; a replacement is a capital purchase that may trigger a formal bid process and, for equipment charged against a federal award, the prior-approval and property-management requirements in 2 CFR 200.313 — including, for federally-owned equipment specifically, formal disposition reporting.
Lifecycle Planning: Turning the Inventory Into a Capital Replacement Plan
The payoff of maintaining accurate inventory, tagging, and both useful-life numbers together is a capital equipment replacement plan built from real data rather than annual guesswork. A useful multi-year plan pulls, per equipment category, the age distribution of the current fleet against typical service-life benchmarks, which units are approaching or have crossed their book depreciation life, which units already carry a rising-repair-frequency flag, and which are covered by an active hazard notice. That combined view — not the depreciation schedule alone, and not the maintenance log alone — is what lets a capital budget request name specific units and a specific rationale rather than an undifferentiated “equipment replacement” line item, and it’s the same underlying inventory data that supports the risk-based inclusion criteria a Joint Commission-facing medical equipment management plan has to document.
Sourcing note: for institutions actively replacing aging diagnostic, monitoring, or imaging equipment identified through this kind of lifecycle review, CASRAI’s sister medical-supply operation LAC maintains a diagnostic, monitoring & imaging equipment category. This is a practical sourcing pointer for units flagged for replacement through the framework above, not a product recommendation for any specific model.
Frequently Asked Questions
Is an equipment inventory the same thing as a medical equipment management plan?
No. The inventory is the underlying record — what equipment exists, where it is, and its condition/financial data. The medical equipment management plan is the written document a Joint Commission-accredited hospital produces under EC.02.04.01 describing how that inventory is built, risk-scored, and maintained. A hospital needs an accurate inventory to write a credible plan, but the inventory itself isn’t the compliance document.
Should RFID replace barcode tagging for equipment tracking?
Usually not entirely — most programs use barcode tags as the baseline for the full fleet (cheap, no reader infrastructure required) and add RFID selectively for high-value or frequently-relocated equipment classes where real-time location matters enough to justify reader infrastructure. Few institutions RFID-tag every asset from day one.
Does the FDA’s UDI rule mean I don’t need my own internal asset tags?
No. The UDI identifies the device model and production batch at the manufacturer level (via the Device Identifier and Production Identifier); it doesn’t identify which specific unit your institution owns, where it’s located, or when it’s next due for maintenance. Capture the UDI as one field in the inventory record — it’s useful for cross-referencing recalls — but it doesn’t substitute for an internal asset ID and physical tag.
What’s the difference between depreciation life and the service-life number biomedical engineering tracks?
Depreciation life (tax and book) is an accounting input set by IRS tables or institutional policy, largely independent of the device’s actual physical condition. The operational service-life estimate is a condition-based judgment from actual failure history, usage, and parts availability. They frequently diverge — see the dedicated section above and CASRAI’s medical equipment depreciation life guide for the full accounting-side breakdown.
